Millstone Evans Group’s Exact Sciences EXAS Stock Holding History

Millstone Evans Group’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-228	Closed	-$23.2K	–	869
2025 Q4	$23.2K	Hold	228	–	–	0.01%	456
2025 Q3	$12.5K	Hold	228	–	–	0.01%	508
2025 Q2	$12.1K	Hold	228	–	–	0.01%	505
2025 Q1	$9.87K	Hold	228	–	–	0.01%	526
2024 Q4	$12.8K	Buy	+228	New	+$14.2K	0.01%	470

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Millstone Evans Group's EXAS Position: Q1 2026 in Review

Millstone Evans Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 228 shares — an estimated $23.2K sold.

Millstone Evans Group first reported a position in EXAS in Q4 2024 and held it in 5 quarters. The position peaked at $23.2K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Millstone Evans Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Millstone Evans Group sold 228 Exact Sciences shares in Q1 2026, an estimated $23.2K.
Millstone Evans Group first reported a position in Exact Sciences in Q4 2024 and held it in 5 quarters.
Millstone Evans Group's Exact Sciences position peaked at $23.2K in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Millstone Evans Group's 13F filing for Q1 2026, filed 30 Apr 2026.